SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-052476
Filing Date
2023-06-28
Accepted
2023-06-28 16:31:33
Documents
5
Period of Report
2023-06-28

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea181062-6k_mainzbio.htm 6-K 24226
2 OPINION OF CMS DERKS STAR BUSMANN N.V ea181062ex5-1_mainzbio.htm EX-5.1 47398
3 PRE-PAID ADVANCE AGREEMENT, DATED JUNE 28, 2023, BETWEEN MAINZ BIOMED N.V. AND Y ea181062ex10-1_mainzbio.htm EX-10.1 257051
4 FORM OF PROMISSORY NOTE TO BE ISSUED UNDER THE PPA ea181062ex10-2_mainzbio.htm EX-10.2 105012
5 BOARD MINUTES REGARDING THE ANNUAL GENERAL MEETING DATED JUNE 28, 2023 ea181062ex99-1_mainzbio.htm EX-99.1 11180
  Complete submission text file 0001213900-23-052476.txt   445929
Mailing Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129
Business Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129 49 6131 5542860
MAINZ BIOMED N.V. (Filer) CIK: 0001874252 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41010 | Film No.: 231052644
SIC: 2834 Pharmaceutical Preparations